European Union states greenlit a measure to regulate artificial intelligence. The sweeping law is the first of its kind and will have a definitive impact on any companies that employ the use of AI. Anne-Gabrielle Haie, a partner with Steptoe LLP, answers questions about the AI Act and discusses its potential impact on the medical device industry...

The company has informed customers that the system will no longer be available or supported after June 20.

Akili had all the ingredients for success. It was in the prescription therapeutics space and went through a high-profile special purpose acquisition corporation merger. Now, the company, once valued at about $1 billion, is being acquired by Virtual Therapeutics for $34 million.

A good minimum viable product can help convince stakeholders, validate concepts, and provide crucial momentum for startups.

This month, companies including Philips Respironics, Abbott, and Masimo were caught in the crosshairs of FDA ire.

The two-phase project will make the German supplier to medical device and pharma OEMs one of the largest employers in Peachtree City.